Stability-indicating spectrophotometric and spectrofluorimetric methods for determination of alfuzosin hydrochloride in the presence of its degradation products

Pharmazie

Volumn 62, Issue 11, 2007, Pages 830-835

  Fayed, Ahmad S ^a   Shehata, M A ^a   Hassan, N Y ^a   Weshahy, S A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN;

ARTICLE; CONTROLLED STUDY; DEGRADATION; DRUG STRUCTURE; HUMAN; SOLID PHASE EXTRACTION; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY;

ADRENERGIC ALPHA-ANTAGONISTS; CALIBRATION; HUMANS; INDICATORS AND REAGENTS; OXIDATION-REDUCTION; QUINAZOLINES; REFERENCE STANDARDS; SOLVENTS; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TABLETS;

EID: 36348977414     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.11.7082     Document Type: Article

References (20)

1. 1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia. J Clin Pharmacol Therap 40: 289-294.
2. Baeye WG, DeKeukeleire D, Korkidis K (1991) Luminescence Techniques in Chemical and Biochemical Analysis, Marcel Dekker Inc. New York, Chapter 3, p. 97.
3. Barry MJ, Roehrborn CG (2001) Benign prostatic hyperplasia. BMJ 323: 1042-1046.
4. Bernardo De, Weigele M, Toome V, Manhart K, Leimgruber W, Boehlen P, Stein S, Undenfriend S (1974) Studies on reaction of fluorescamine with primary amines. Arch Biochem Biophys 163: 390-399.
5. Carlucci G, Di-Giuseppe E, Mazzeo P (1994) Determination of alfuzosin in human plasma by high-performance liquid-chromatography with column switching. J Liq Chromatogr 17: 3989-3997.
6. Cerretero AS, Blanco CC, Peinado SF, ElBergmi R, Gutierrez AF (1999) Fluorimetric determination of procaine based on its reaction with fluorescamine. J Pharm Biomed Anal 21: 969-974.
7. Fayed AS, Shehata MA, Hassan NY, Weshahy SA (2006) Validated HPLC and HPTLC stability-indicating methods for determination of alfuzosin hydrochloride in bulk powder and pharmaceutical formulation. J Separ Sci 29: 2716-2724.
8. Guinebault P, Broquaire M, Colafrancesch C, Thenot JP (1986) High-performance liquid-chromatography determination of alfuzosin in biological fluids with fluorimetric detection and large-volume injection. J Chromatogr 353: 361-369.
9. Henry SI, Beiser C (1975) Rapid fluorimetric determination of procainamide hydrochloride in dosage form. J Pharm Sci 64: 1207-1210.
10. International Conference on Harmonization (October 1993) Stability Testing of New Drug Substances and Products, Geneva.
11. International Conference on Harmonization (November 1996) Validation of Analytical Procedures: Methodology (Q2B).
12. Klein B, Sheehan JE, Gruenberg E (1974) Use of fluorescamine ("Fluram") to detect amphetamine in urine by thin-layer chromatography. Clin Chem 20: 272-274.
13. Lurie Ju (1978) Handbook of Analytical Chemistry, Mir Publishers, Moscow; p. 263.
14. th Ed. Pearson Education Ltd, London p. 98.
15. Rhodes PR, Krogh RH, Bruskewitz RC (1999) Impact of drug therapy on benign prostatic hyperplasia - specific quality of life. Urology 53: 1090-1098.
16. Rose J (1964) Advanced Physicochemical Experiments Pitman, London; p. 67.
17. th Ed. The Complete Drug References. The Pharmaceutical Press, London, p. 856-858.
18. Uslu B (2002) Voltammetric analysis of alfuzosin HCl in pharmaceuticals, human serum, and simulated gastric juice. Electroanalysis 14: 866-870.
19. Weisner JL, Sutherland FCW, Van-Essen GH, Hundt HKL, Swart KJ, Hundt AF (2003) Selective, sensitive and rapid liquid chromatography - tandem mass spectrometry method for the determination of alfuzosin in human plasma. J Chromatogr B: Anal Tecnnol Biomed Life Sci 788: 361-368.
20. Yao Hw, Jin Y, Li J, Zhang YF, Ding XN, Xu Sy (2002) Determination of alfuzosin in human plasma by RP-HPLC with fluorimetric detection. Yaowu-Fenxi-Zazhi 22: 127-129.